• Who Won the 2020 Nobel Prize in Physiology or Medicine?

Microscopy & Microtechniques

Who Won the 2020 Nobel Prize in Physiology or Medicine?

Dec 02 2020

Introduced by Swedish chemist Alfred Nobel in 1895, Nobel Prizes are awarded "to those who, during the preceding year, have conferred the greatest benefit to humankind”. In 2020 the coveted Nobel Prize in Physiology or Medicine 2020 was presented jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of the Hepatitis C Virus (HCV). The trio made significant contributions to mapping the blood-borne virus, which currently infects around 71 million people around the world. Chronic infections can lead to severe health issues, including cirrhosis and liver cancer.

Understanding chronic hepatitis

Globally, blood-borne hepatitis viruses are currently responsible for more than 1 million deaths a year. This places Hepatitis C as a global health concern, comparable to infectious diseases like tuberculosis and human immunodeficiency virus (HIV). Prior to the discovery of Hepatitis C, little was known about blood-borne viruses. While Hepatitis A and B were discovered in the 1940s, the discovery of HCV offered scientists insight into the causes of chronic hepatitis. It also helped to develop new blood tests and medicines to treat the condition.

Mapping the genetic profile of HCV

When developing successful treatments for viruses the key is to pinpoint the causative trigger. Before the pioneering work of Alter, Houghton and Rice, scientists were unable to identify a form of chronic viral hepatitis known as “non-A, non-B” hepatitis. During his work at a pharmaceutical firm Houghton successfully isolated the genetic sequence of the unknown virus. He then created a set of DNA fragments using nucleic acids extracted from an infected chimpanzee. Fluids extracted from chronic hepatitis patients were then used to detect a positive clone for viral antibodies. The clone was then identified in a novel RNA virus, which was named Hepatitis C.

Piecing together the puzzle

Charles M. Rice uncovered more pieces of the puzzle by investigating whether the cloned virus could replicate and spark a hepatitis infection. As well as identifying a region of the Hepatitis C virus genome responsible for replication, the team noted genetic variations that could hinder reproduction. After testing the RNA variant on chimpanzee livers Rice and his team were able to prove the Hepatitis C virus can cause infections.

Thanks to the work of Alter, Houghton and Rice, hepatitis patients around the world now have access to ultra-sensitive blood tests and antiviral drugs. The findings were a breakthrough for global health, with the trio awarded one of the highest accolades in science for their contributions.

Find out more about the latest scientific breakthroughs in ‘Micropatterning: The art of micro-controlling cells’ featuring insight from Marie-Charlotte Manus, Dr Louise Bonnemay and Matthieu Opitz on behalf of Alvéole.


Digital Edition

Labmate UK & Ireland November 2021

November 2021

In This Edition Articles - Advancements in Freeze drying production and the impacts on scale, sustainability and compliance - Face-to-face events finally start up - But how will attendance f...

View all digital editions

Events

Lab Asia 2021 - POSTPONED TO 2022

Nov 30 2021 Virtual event

Pharma Asia - NEW DATES

Dec 08 2021 Islamabad, Pakistan

LABWorld China 2021

Dec 16 2021 SNIEC Shanghai, China & online

Miconex

Dec 22 2021 Beijing, China

View all events